Venclexta and Pregabalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Venclexta (venetoclax) and Pregabalin (pregabalin). Common drug interactions include lymph node tuberculosis among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Venclexta and Pregabalin. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

On Jul, 24, 2026

76 people who take Venclexta and Pregabalin together, and have interactions are studied.

Venclexta and Pregabalin drug interactions.

What are the common drug interactions of Venclexta and Pregabalin, by gender? *:

female:

Lymph node tuberculosis
Lymphadenopathy (disease or enlargement of lymph nodes)
Mass
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Pyrexia (fever)
Rhinorrhoea (watery mucus discharge from the nose)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Cytomegalovirus infection
Diarrhoea
Fall

male:

Febrile neutropenia (fever with reduced white blood cells)
Cryptococcosis (potentially fatal fungal disease)
Hypertension (high blood pressure)
Hypokalaemia (low potassium)
Leukopenia (less number of white blood cells in blood)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Oedema peripheral (superficial swelling)
Vomiting
Arrhythmia (irregular heartbeat)
Death

What are the common drug interactions of Venclexta and Pregabalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Appetite disorder (abnormal eating habits)
Asthenia (weakness)
Blood calcium decreased

40-49:

n/a

50-59:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood phosphorus decreased
Fatigue (feeling of tiredness)
Feeling hot
Hepatic enzyme increased
Hyperhidrosis (abnormally increased sweating)

60+:

Febrile neutropenia (fever with reduced white blood cells)
Cryptococcosis (potentially fatal fungal disease)
Epistaxis (bleed from the nose)
Hypertension (high blood pressure)
Hypokalaemia (low potassium)
Leukopenia (less number of white blood cells in blood)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Oedema peripheral (superficial swelling)
Arrhythmia (irregular heartbeat)
Hospitalisation

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 23 people, 30.26%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 22.37%
High Blood Pressure: 8 people, 10.53%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 7 people, 9.21%
Pain: 6 people, 7.89%
Neuropathy Peripheral (surface nerve damage): 5 people, 6.58%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 6.58%
Multiple Myeloma (cancer of the plasma cells): 4 people, 5.26%
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 4 people, 5.26%
Depression: 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Venclexta and Pregabalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously